Literature DB >> 2183525

[Generalized tendomyopathy. I: Clinical aspects, follow-up and differential diagnosis].

W Müller1, J Lautenschläger.   

Abstract

Generalized tendomyopathy (GTM), or fibromyalgia, is a disorder characterized by diffuse pain in the musculoskeletal apparatus which usually begins at a single site, e.g., as low-back pain or cervical syndrome, and develops into generalized pain over months or years. It is accompanied by increased tenderness at characteristic tender points, although the pain threshold on the whole is reduced. In addition to the main symptoms (pain in the musculoskeletal system, tenderness at the tender points), autonomic and functional symptoms are almost invariably present and are often accompanied by pathological psychological findings such as neuroses and depression. To date, no reliable laboratory parameters or pathognomonic histological findings have been identified. The disorder affects primarily women, beginning around the age of 35 and reaching its peak during or after the menopause. It also affects young people and those over age 60, although it is much less common in these cases. Secondary forms are observed particularly in rheumatoid arthritis. The differential diagnosis must first distinguish primary GTM from the secondary forms. There must also be further differentiation between internal and psychiatric disorders and primary GTM. This can be achieved in many cases by careful clinical diagnosis, although a more complete examination is sometimes required.

Entities:  

Mesh:

Year:  1990        PMID: 2183525

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  12 in total

1.  Tissue oxygen measurement and 31P magnetic resonance spectroscopy in patients with muscle tension and fibromyalgia.

Authors:  E S Strobel; M Krapf; M Suckfüll; W Brückle; W Fleckenstein; W Müller
Journal:  Rheumatol Int       Date:  1997       Impact factor: 2.631

2.  [Causal illness attributions and healthcare utilization in fibromyalgia syndrome].

Authors:  W Häuser; R Wilhelm; W Klein; C Zimmer
Journal:  Schmerz       Date:  2006-04       Impact factor: 1.107

Review 3.  [5-HT3 receptor antagonist als analgetics in rheumatic diseases].

Authors:  W Müller; B L Fiebich; T Stratz
Journal:  Z Rheumatol       Date:  2006-10       Impact factor: 1.372

Review 4.  [Fibromyalgia--a challenge for interdisciplinary management].

Authors:  Gerhard Fürst
Journal:  Wien Med Wochenschr       Date:  2007-01

5.  Fibromyalgia syndrome: classification, diagnosis, and treatment.

Authors:  Winfried Häuser; Wolfgang Eich; Markus Herrmann; Detlev O Nutzinger; Marcus Schiltenwolf; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2009-06-05       Impact factor: 5.594

6.  [What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association].

Authors:  W Häuser; C Zimmer; E Felde; V Köllner
Journal:  Schmerz       Date:  2008-04       Impact factor: 1.107

7.  [Clinical features, pathophysiology and treatment of fibromyalgia.].

Authors:  H C Müller-Busch
Journal:  Schmerz       Date:  1994-09       Impact factor: 1.107

8.  Cold-induced vasospasm in patients with fibromyalgia and chronic low back pain in comparison to healthy subjects.

Authors:  E Lapossy; P Gasser; P Hrycaj; B Dubler; W Samborski; W Muller
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

9.  [Steps towards a symptom-based diagnosis of fibromyalgia syndrome. Symptom profiles of patients from different clinical settings].

Authors:  W Häuser; I Akritidou; E Felde; S Klauenberg; C Maier; A Hoffmann; V Köllner; A Hinz
Journal:  Z Rheumatol       Date:  2008-10       Impact factor: 1.372

10.  [Fibromyalgia].

Authors:  W Brückle; H Zeidler
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.